Jeena Sikho Lifecare Limited (JSLL) has announced a series of significant changes in its leadership and employee benefits structure, as approved by its Board of Directors on August 27, 2025.

New Chief Operating Officer

The company has appointed Sahil Jain as its new Chief Operating Officer (COO), effective August 27, 2025. Jain brings over eight years of experience within JSLL, having previously led key departments including IT, Marketing, Call Center Operations, and Administration. His background also includes valuable experience at global technology firms IBM and HCL Australia.

Employee Stock Option Scheme 2025

JSLL's Board has approved an Employee Stock Option Scheme (ESOP) 2025, subject to shareholder approval. The scheme will cover up to 250,000 stock options at an exercise price of Rs. 2.00 per share. This initiative aims to benefit eligible employees and directors of the company and its group companies.

Board Changes

In a significant board restructuring, Shreya Grover has been redesignated from Non-Executive Director to Whole-Time Director for a five-year term, effective August 27, 2025. Grover, who is the daughter of Managing Director Manish Grover, has been associated with the company since June 2021. Her new role will focus on guiding the company's growth strategies, including the expansion of Ayurveda hospitals and the launch of OTC Ayurveda products.

Other Key Decisions

The Board made several other important decisions:

• Appointment of Ankur Singh & Associates as Secretarial Auditor for a five-year term from FY 2025-26 to FY 2029-30.
• Scheduling of the 8th Annual General Meeting (AGM) for September 29, 2025.
• Recommendation of a final dividend of Rs. 1.10 per equity share for the financial year ended March 31, 2025, subject to shareholder approval.

Financial Implications

The proposed ESOP scheme and dividend payout indicate the company's focus on employee retention and shareholder value. However, the financial impact of these decisions will be clearer in the coming quarters.

These developments suggest that Jeena Sikho Lifecare is positioning itself for growth and expansion in the Ayurveda and wellness sector, with a renewed focus on operational efficiency and strategic leadership.

Jeena Sikho Lifecare Limited, a prominent player in the Ayurvedic and natural health sector, has launched India's first Pet-Yakrit-Pleeha Shuddhi Kit, designed for triple detoxification of the gut, liver, and spleen. The groundbreaking product was unveiled during a press conference held at the Radisson Lucknow City Center.

Revolutionary Product Launch

The event, addressed by Acharya Manish Ji and Dr. Neha, showcased the company's latest innovation in holistic health care. The Pet-Yakrit-Pleeha Shuddhi Kit is the culmination of over 20 years of research, clinical trials, and successful patient outcomes. It targets lifestyle-related diseases, focusing on treating root causes rather than just symptoms.

Comprehensive Detoxification Approach

The kit offers a unique approach to health by simultaneously addressing the detoxification needs of three vital organs:

1. Pet (Gut): Focusing on digestive health and overall gut function
2. Yakrit (Liver): Targeting liver detoxification and metabolic processes
3. Pleeha (Spleen): Aiming to enhance the immune system and blood purification

This triple-action approach sets the product apart in the growing market for natural health solutions.

Regulatory Compliance and Transparency

In compliance with regulatory requirements, Jeena Sikho Lifecare Limited promptly informed both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) about the product launch through a filing. This move underscores the company's commitment to transparency and adherence to listing obligations.

Future Prospects and Corporate Developments

The launch of this innovative product comes at a time when the company is also considering other significant corporate actions. As per a separate regulatory filing, Jeena Sikho Lifecare Limited has scheduled a Board of Directors meeting to discuss and potentially approve an Employee Stock Option Scheme.

Market Impact and Industry Significance

The introduction of the Pet-Yakrit-Pleeha Shuddhi Kit represents a significant step in the Ayurvedic and natural health products industry. It showcases the company's dedication to research and development, potentially positioning Jeena Sikho Lifecare as a leader in innovative health solutions.

As the market for natural and holistic health products continues to grow, this launch could have far-reaching implications for both the company's market position and the broader industry landscape.

Investors and health enthusiasts alike will be watching closely to see how this new product performs in the market and what it might mean for the future of natural health solutions in India and beyond.